0001806356-24-000001.txt : 20240711 0001806356-24-000001.hdr.sgml : 20240711 20240711142558 ACCESSION NUMBER: 0001806356-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240711 DATE AS OF CHANGE: 20240711 EFFECTIVENESS DATE: 20240711 FILER: COMPANY DATA: COMPANY CONFORMED NAME: 858 Therapeutics, Inc. CENTRAL INDEX KEY: 0001806356 ORGANIZATION NAME: IRS NUMBER: 834651777 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-518431 FILM NUMBER: 241111803 BUSINESS ADDRESS: STREET 1: 4757 NEXUS CENTER DRIVE STREET 2: SUITE 150 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-987-8380 MAIL ADDRESS: STREET 1: 4757 NEXUS CENTER DRIVE STREET 2: SUITE 150 CITY: SAN DIEGO STATE: CA ZIP: 92121 D 1 primary_doc.xml X0708 D LIVE 0001806356 858 Therapeutics, Inc. 3115 Merryfield Row Suite 110 SAN DIEGO CA CALIFORNIA 92121 858-987-8380 DELAWARE None None Corporation true Stafford Jeffrey c/o 858 Therapeutics, Inc. 3115 Merryfield Row, Suite 110 San Diego CA CALIFORNIA 92121 Executive Officer Director Clare Ozawa c/o 858 Therapeutics, Inc. 3115 Merryfield Row, Suite 110 San Diego CA CALIFORNIA 92121 Director Ali Behbahani c/o 858 Therapeutics, Inc. 3115 Merryfield Row, Suite 110 San Diego CA CALIFORNIA 92121 Director Monal Mehta c/o 858 Therapeutics, Inc. 3115 Merryfield Row, Suite 110 San Diego CA CALIFORNIA 92121 Director Jane Huang c/o 858 Therapeutics, Inc. 3115 Merryfield Row, Suite 110 San Diego CA CALIFORNIA 92121 Director James Veal c/o 858 Therapeutics, Inc. 3115 Merryfield Row, Suite 110 San Diego CA CALIFORNIA 92121 Executive Officer Katherine Bell-McGuinn c/o 858 Therapeutics, Inc. 3115 Merryfield Row, Suite 110 San Diego CA CALIFORNIA 92121 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2024-06-26 false true false 0 50350497 25175501 25174996 false 12 0 0 0 false 858 Therapeutics, Inc. Jeffrey A. Stafford Jeffrey A. Stafford President and Chief Executive Officer 2024-07-11